Costs of bipolar disorder

Area of Science:

• Psychiatry
• Health Economics

Background:

• Bipolar disorder is a chronic affective disorder with a 1.3% lifetime prevalence.
• It is characterized by recurrent mania/hypomania and depressive episodes, impairing functioning and quality of life.
• The disorder imposes a significant economic burden on patients, families, and society.

Purpose of the Study:

• To review the symptomatology of bipolar disorder and identify treatment challenges.
• To examine methods for assessing direct and indirect costs associated with bipolar disorder.
• To report on comprehensive cost studies and economic burden evaluations.

Main Methods:

• Review of comprehensive cost-of-illness studies.
• Analysis of administrative claims data and program evaluations.
• Inclusion of US-based studies and relevant European research.

Main Results:

• Bipolar disorder incurs substantial economic costs, with annual estimates reaching $45.2 billion (1991 values) in one study.
• Hospitalization remains a major direct cost, while outpatient services and indirect costs (morbidity, mortality) are significant.
• Intangible costs like family burden and reduced quality of life are prevalent but difficult to quantify monetarily.

Conclusions:

• Bipolar disorder presents significant treatment challenges and a considerable economic burden.
• Effective management requires addressing both direct medical costs and indirect/intangible costs.
• Further research into cost-effectiveness of interventions and quantifying intangible costs is warranted.